Johnson & Johnson's slackening second quarter sales
Healthcare giant Johnson & Johnson reported a dip in sales last week, with sales of $17.8 billion for the second quarter of 2015 – down 8.8 per cent on the same period a year earlier.
“We’ve continued to invest in building a robust enterprise pipeline that will drive our growth over the long term.”
Alex Gorsky, Johnson & Johnson’s chief executive
